The FDA has just authorized, for the first time, a direct-to-consumer (DTC) genetic test to report on three genetic variants found on BRCA1 and BRCA2 genes. These genetic variants are known to increase a person’s risk for developing primarily breast cancer, but also also ovarian or prostate cancers.
Category: Health & Wellbeing
- New Sema4 DNA test screens your child for 193 genetic diseases
- Ancient mummy DNA reveals surprises about genetic origins of Egyptians
- FDA approves home genetic tests for Alzheimer’s and other diseases
- FDA approves another gene therapy, this time for treating inherited vision loss
- Mutations in a single gene linked to severe obesity
- New CRISPR tools enable extraordinarily precise gene editing in human cells